LIFESTANCE HEALTH ($LFST) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of $0.03 per share, beating estimates of -$0.00 by $0.03. The company also reported revenue of $382,200,000, missing estimates of $383,831,895 by $-1,631,895.
You can see Quiver Quantitative's $LFST stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LIFESTANCE HEALTH Insider Trading Activity
LIFESTANCE HEALTH insiders have traded $LFST stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $LFST stock by insiders over the last 6 months:
- ROBERT BESSLER has made 0 purchases and 10 sales selling 220,086 shares for an estimated $1,546,264.
- LISA K MILLER (See Remarks) sold 57,240 shares for an estimated $368,053
- ANN VARANAKIS (Chief People Officer) sold 50,000 shares for an estimated $345,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LIFESTANCE HEALTH Hedge Fund Activity
We have seen 128 institutional investors add shares of LIFESTANCE HEALTH stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 13,055,317 shares (-68.1%) from their portfolio in Q4 2025, for an estimated $91,909,431
- FMR LLC added 7,840,028 shares (+20.1%) to their portfolio in Q4 2025, for an estimated $55,193,797
- WELLINGTON MANAGEMENT GROUP LLP removed 4,571,711 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $25,144,410
- AUSTRALIANSUPER PTY LTD removed 3,101,010 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $21,831,110
- VANGUARD GROUP INC added 3,086,506 shares (+21.1%) to their portfolio in Q4 2025, for an estimated $21,729,002
- BROWN ADVISORY INC removed 2,997,842 shares (-88.5%) from their portfolio in Q4 2025, for an estimated $21,104,807
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 1,703,725 shares (-79.3%) from their portfolio in Q4 2025, for an estimated $11,994,224
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LIFESTANCE HEALTH Analyst Ratings
Wall Street analysts have issued reports on $LFST in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 11/13/2025
- UBS issued a "Buy" rating on 11/07/2025
- BTIG issued a "Buy" rating on 11/06/2025
To track analyst ratings and price targets for LIFESTANCE HEALTH, check out Quiver Quantitative's $LFST forecast page.
LIFESTANCE HEALTH Price Targets
Multiple analysts have issued price targets for $LFST recently. We have seen 4 analysts offer price targets for $LFST in the last 6 months, with a median target of $9.0.
Here are some recent targets:
- David Larsen from BTIG set a target price of $11.0 on 02/02/2026
- Peter Warendorf from Barclays set a target price of $8.0 on 12/09/2025
- Sean Dodge from BMO Capital set a target price of $8.0 on 11/13/2025
- Kevin Caliendo from UBS set a target price of $10.0 on 11/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
